The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development
Open accessAbstract
MicroRNAs (miRs) regulate gene expression at the posttranscriptional level and play crucial roles in vascular integrity. As such, they may have a role in modifying abdominal aortic aneurysm (AAA) expansion, the pathophysiological mechanisms of which remain incompletely explored. Here, we investigate the role of miRs in 2 murine models of experimental AAA: the porcine pancreatic elastase (PPE) infusion model in C57BL/6 mice and the AngII infusion model in Apoe-/- mice. AAA development was accompanied by decreased aortic expression of miR-29b, along with increased expression of known miR-29b targets, Col1a1, Col3a1, Col5a1, and Eln, in both models. In vivo administration of locked nucleic acid anti-miR-29b greatly increased collagen expression, leading to an early fibrotic response in the abdominal aortic wall and resulting in a significant reduction in AAA progression over time in both models. In contrast, overexpression of miR-29b using a lentiviral vector led to augmented AAA expansion and significant increase of aortic rupture rate. Cell culture studies identified aortic fibroblasts as the likely vascular cell type mediating the profibrotic effects of miR-29b modulation. A similar pattern of reduced miR-29b expression and increased target gene expression was observed in human AAA tissue samples compared with that in organ donor controls. These data suggest that therapeutic manipulation of miR-29b and its target genes holds promise for limiting AAA disease progression and protecting from rupture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Development of a self-inactivating lentivirus vector
Miyoshi, H., Blömer, U., Takahashi, M., Gage, F. H., & Verma, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8150-8157.1998 · Cited by 1,196
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
Roderburg, C., Urban, G.-W., Bettermann, K., Vucur, M., Zimmermann, H., Schmidt, S., Janssen, J., Koppe, C., Knolle, P., Castoldi, M., et al. (2011) · Hepatology · doi:10.1002/hep.23922 · Cited by 803
Abdominal Aortic Aneurysm Expansion: Risk Factors and Time Intervals for Surveillance
Brady, A. R., Thompson, S. G., Fowkes, F. G. R., Greenhalgh, R. M., & Powell, J. T. (2004) · Circulation · doi:10.1161/01.cir.0000133279.07468.9f · Cited by 685
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
Qin, W., Chung, A. C. K., Huang, X. R., Meng, X.-M., Hui, D. S. C., Yu, C.-M., Sung, J. J. Y., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121308 · Cited by 566
Mouse Models of Abdominal Aortic Aneurysms
Daugherty, A., & Cassis, L. A. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000118013.72016.ea · Cited by 488
Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice
Holm, T. M., Habashi, J. P., Doyle, J. J., Bedja, D., Chen, Y., van Erp, C., Lindsay, M. E., Kim, D., Schoenhoff, F., Cohn, R. D., et al. (2011) · Science · doi:10.1126/science.1192149 · Cited by 476
Lessons on the pathogenesis of aneurysm from heritable conditions
Lindsay, M. E., & Dietz, H. C. (2011) · Nature · doi:10.1038/nature10145 · Cited by 473
Wang, Y., Ait-Oufella, H., Herbin, O., Bonnin, P., Ramkhelawon, B., Taleb, S., Huang, J., Offenstadt, G., Combadière, C., Rénia, L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38136 · Cited by 414
Gene delivery by lentivirus vectors
Cockrell, A. S., & Kafri, T. (2007) · Molecular Biotechnology · doi:10.1007/s12033-007-0010-8 · Cited by 355
Regalado, E. S., Guo, D.-C., Villamizar, C., Avidan, N., Gilchrist, D., McGillivray, B., Clarke, L., Bernier, F., Santos-Cortez, R. L., Leal, S. M., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.248161 · Cited by 293
Collagen types and matrix protein content in human abdominal aortic aneurysms
Rizzo, R. J., McCarthy, W. J., Dixit, S. N., Lilly, M. P., Shively, V. P., Flinn, W. R., & Yao, J. S. T. (1989) · Journal of Vascular Surgery · doi:10.1016/0741-5214(89)90409-6 · Cited by 276
Chen, K.-C., Wang, Y.-S., Hu, C.-Y., Chang, W.-C., Liao, Y.-C., Dai, C.-Y., & Juo, S.-H. H. (2011) · The FASEB Journal · doi:10.1096/fj.10-174904 · Cited by 209
MicroRNomics: a newly emerging approach for disease biology
Zhang, C. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00034.2008 · Cited by 204
Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms
Thompson, R. W., Liao, S., & Curci, J. A. (1997) · Coronary Artery Disease · doi:10.1097/00019501-199710000-00005 · Cited by 177
Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II.
Paepe, A. D., Nuytinck, L., Haußer, I., Anton‐Lamprecht, I., & Naeyaert, J. M. (1997) · Europe PMC (PubMed Central) · Cited by 166
MicroRNAs as a therapeutic target for cardiovascular diseases
Mishra, P. K., Tyagi, N., Kumar, M., & Tyagi, S. C. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00744.x · Cited by 148
Overexpression of Transforming Growth Factor-β1 Stabilizes Already-Formed Aortic Aneurysms
Dai, J., Losy, F., Guinault, A.-M., Pages, C., Anegón, I., Desgranges, P., Becquemin, J., & Allaire, É. (2005) · Circulation · doi:10.1161/circulationaha.104.523357 · Cited by 142
Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling
Zhang, J., Nie, L., Razavian, M., Ahmed, M., Dobrucki, L. W., Asadi, A., Edwards, D. S., Azure, M. T., Sinusas, A. J., & Sadeghi, M. M. (2008) · Circulation · doi:10.1161/circulationaha.108.789743 · Cited by 110
Liao, M., Zou, S., Weng, J., LeWei, H., Yang, L., Zhao, Z., Bao, J., & Jing, Z. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2010.11.113 · Cited by 106
Frutkin, A. D., Otsuka, G., Stempien‐Otero, A., Sesti, C., Du, L., Jaffe, M., Dichek, H. L., Pennington, C. J., Edwards, D. R., Nieves‐Cintrón, M., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.186593 · Cited by 100
Rahkonen, O. P., Su, M., Hakovirta, H. H., Koskivirta, I., Hormuzdi, S. G., VUORIO, E. I., BORNSTEIN, P. K., & Penttinen, R. P. K. (2003) · Circulation Research · doi:10.1161/01.res.0000108263.74520.15 · Cited by 83
Influences of Aortic Motion and Curvature on Vessel Expansion in Murine Experimental Aneurysms
Goergen, C. J., Azuma, J., Barr, K. N., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.216481 · Cited by 80
Self-citationJuan, A. S., Bala, M., Hlawaty, H., Portes, P., Vranckx, R., Feldman, L. J., & Letourneur, D. (2009) · Biomacromolecules · doi:10.1021/bm900740g · Cited by 76
Nguyen, T.-L. M., Sullivan, N., Ebel, M. E., Teague, R. M., & DiPaolo, R. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004112 · Cited by 59
Creation of Murine Experimental Abdominal Aortic Aneurysms with Elastase
Azuma, J., Asagami, T., Dalman, R. L., & Tsao, P. S. (2009) · Journal of Visualized Experiments · doi:10.3791/1280 · Cited by 56
Self-citationAtherosclerotic Vascular Disease Conference: Writing Group V: Medical Decision Making and Therapy
Creager, M. A., Jones, D. W., Easton, J. D., Halperin, J. L., Hirsch, A. T., Matsumoto, A. H., O’Gara, P. T., Safian, R. D., Schwartz, G. L., & Spittell, J. A. (2004) · Circulation · doi:10.1161/01.cir.0000128522.98016.19 · Cited by 52
Optimizing gene delivery vectors for the treatment of heart disease
Gray, S. J., & Samulski, R. J. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.911 · Cited by 48
Azuma, J., Mäegdefessel, L., Kitagawa, T., Dalman, R. L., McConnell, M. V., & Tsao, P. S. (2011) · BioMed Research International · doi:10.1155/2011/252141 · Cited by 26
Self-citation
Cited by
Chaikof, E. L., Dalman, R. L., Eskandari, M. K., Jackson, B. M., Lee, W. A., Mansour, M. A., Mastracci, T. M., Mell, M., Murad, M. H., Nguyen, L. L., et al. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.10.044 · Cited by 2,751
Self-citationAngiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Abdominal aortic aneurysm: update on pathogenesis and medical treatments
Golledge, J. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0114-9 · Cited by 788
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
van Rooij, E., & Olson, E. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3864 · Cited by 624
Brozovich, F. V., Nicholson, C. J., Degen, C. V., Gao, Y. Z., Aggarwal, M., & Morgan, K. G. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.010652 · Cited by 542
Metadata
- Authors
- Maegdefessel, L., Azuma, J., Toh, R., Merk, D. R., Deng, A., Chin, J. T., Raaz, U., Schoelmerich, A. M., Raiesdana, A., Leeper, N. J., McConnell, M. V., Dalman, R. L., Spin, J. M., & Tsao, P. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-02-01
- Volume
- 122
- Issue
- 2
- Pages
- 497-506
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2146104000
- Cited by
- 306
- References
- 29
- FWCI
- 20.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.